Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on March 27, 2024. The transactions were executed in the open market with prices ranging from $105.73 to $110.75 per share, resulting in a total market value of $1,635,864.09. Following the sales, Afeyan directly holds 2,101,931 shares of Moderna. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. total 9,666,038 shares.